DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-002399-28-IT (EUCTR)	14/07/2017	23/01/2018	Rapamycin (Sirolimus) treatment for amyotrophic lateral sclerosis	Rapamycin (Sirolimus) treatment for amyotrophic lateral sclerosis - RAP.ALS	definite or probable ALS MedDRA version: 20.0;Level: PT;Classification code 10002026;Term: Amyotrophic lateral sclerosis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Trade Name: RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE Product Name: Rapamune	AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	63	Phase 2	Italy

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

EUCTR2016-002399-28-IT
(EUCTR)

14/07/2017

23/01/2018

Rapamycin (Sirolimus) treatment for amyotrophic lateral sclerosis

Rapamycin (Sirolimus) treatment for amyotrophic lateral sclerosis - RAP.ALS

definite or probable ALS
MedDRA version: 20.0;Level: PT;Classification code 10002026;Term: Amyotrophic lateral sclerosis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

Trade Name: RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE
Product Name: Rapamune

AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA

NULL

Authorised-recruitment may be ongoing or finished

Female: yes
Male: yes

Phase 2

Italy